PitchBook:2024年三季度Agtech公共资产负债表和估值指南报告(英文版).pdf |
下载文档 |
资源简介
Overall challenging market conditions weighed on the public agtech sector this quarter, with varied performance across the sector’s market segments. Despite areas such as indoor farming facing significant declines, plant biotech companies are a standout, with fast- and medium-growth companies seeing stock price increases. Projections show that fast-growth plant biotech companies should achieve a 45% median gross profit margin by the end of 2024. Our Q3 2024 Agtech Public Comp Sheet and Valuat
已阅读到文档的结尾了